Carol T. Wismer

A-317491, a novel potent and selective non-nucleotide antagonist of P2X ₃ and P2X _2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat

Michael F. Jarvis, Edward C. Burgard, Steve McGaraughty et al. · Proceedings of the National Academy of Sciences · 2002 · 458 citations · Full text

A-425619 [1-Isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a Novel Transient Receptor Potential Type V1 Receptor Antagonist, Relieves Pathophysiological Pain Associated with Inflammation and Tissue Injury in Rats

Prisca Honoré, Carol T. Wismer, Joe Mikusa et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 254 citations

P2X7-related modulation of pathological nociception in rats

Steve McGaraughty, K. L. Chu, Marian T. Namovic et al. · Neuroscience · 2007 · 220 citations

Health Sciences, Pain Medicine, P2x7-related Modulation +8

Effects of A‐317491, a novel and selective P2X₃/P2X_2/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration

Steve McGaraughty, Carol T. Wismer, Chang Zhu et al. · British Journal of Pharmacology · 2003 · 177 citations · Full text

Novel Transient Receptor Potential Vanilloid 1 Receptor Antagonists for the Treatment of Pain:  Structure−Activity Relationships for Ureas with Quinoline, Isoquinoline, Quinazoline, Phthalazine, Quinoxaline, and Cinnoline Moieties

Arthur Gomtsyan, Erol K. Bayburt, Robert G. Schmidt et al. · Journal of Medicinal Chemistry · 2005 · 163 citations · Full text

Pain Medicine, Immunology, Receptor Antagonists +18